Certification Rate
100%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
Woburn, MA NAICS: 325412
U.S. Department of Labor's OFLC discloses 21 Labor Condition Application filings naming Continuus Pharmaceuticals, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 26 H-1B petitions naming Continuus Pharmaceuticals, Inc. through FY2023, and approved nearly every one of them: 100% approved (26 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Continuus Pharmaceuticals, Inc. is listed in 21 DOL LCA filings, more filings than 91% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $128,357. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Woburn, MA.
Continuus Pharmaceuticals, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
21 10911th of 122824 higher than 111,913 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $85,000–$205,000 .
DOL LCA release change
On 21 LCAs with comparable offered vs prevailing wages, Continuus Pharmaceuticals, Inc. averages about 22.2% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Qualified (Level II) (47.6% of LCA filings).
Completed-year LCA counts fell from 13 in FY2023 to 2 in FY2025 (≈15% of the earlier year). Cumulative volume still 21.
Only 21 LCAs on file for Continuus Pharmaceuticals, Inc., and 100% land in WOBURN CITY, MA. Treat rates as descriptive of a small sample. DOL cert on file: 100%.
Certification Rate
100%
Very high DOL cert
Avg. Salary
$128,357
Above portal avg
Total Workers
21
Small worker count
Compensation range for H-1B positions at Continuus Pharmaceuticals, Inc.
Wage vs. DOL Minimum
+22.2%
Above DOL floor
national avg +17.8%
Typical DOL Wage Level
Qualified (Level II)
47.6% of LCA filings
Full-Time Positions
100%
Primary Worksite County
WOBURN CITY, MA
100% of LCA filings
Most frequently listed job titles at Continuus Pharmaceuticals, Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Validation Project Lead | 2 | $125,000 |
| Scientist 1 Analytical Chemistry | 2 | $110,000 |
| Reaction Engineering Manager | 2 | $144,000 |
| Associate Scientist Process Engineer | 2 | $90,000 |
| Senior Analytical Scientist | 1 | $130,000 |
| Scientist, Analytical Chemistry | 1 | $85,000 |
| Scientist I Process Engineering | 1 | $120,000 |
| Quality Assurance Manager | 1 | $155,000 |
| Process Chemist | 1 | $110,000 |
| Process Analytical Technology (PAT) Scientist | 1 | $125,000 |
| Lead Computer Systems Validation Engineer | 1 | $120,000 |
| Formulation Scientist | 1 | $117,500 |
| Engineer I, Mechanical Engineering | 1 | $105,000 |
| Director Quality | 1 | $185,000 |
| Director Engineering | 1 | $205,000 |
Cross-state DOL neighbors for Continuus Pharmaceuticals, Inc. - LCA filing-count and offered-wage axes, outside MA.
Nearest cross-state employer filers by LCA filing count (21 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($128,357 here).
Continuus Pharmaceuticals, Inc. is listed in 21 DOL Labor Condition Application filings covering 21 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, Continuus Pharmaceuticals, Inc. ranks #10523 by total LCA filing count (21 filings). 111,913 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
Continuus Pharmaceuticals, Inc. has a 100% DOL certification rate, with 21 out of 21 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in Continuus Pharmaceuticals, Inc.'s LCAs is $128,357. Listed wages range from $85,000 to $205,000 and are not verified actual compensation.
The top job titles in Continuus Pharmaceuticals, Inc.'s LCA filing records include Validation Project Lead, Scientist 1 Analytical Chemistry, Reaction Engineering Manager. The most common listed title is Validation Project Lead with 2 LCA filings at an average listed offered wage of $125,000. This does not establish actual job openings, hiring, or approved petitions.
Continuus Pharmaceuticals, Inc. is headquartered in Woburn, MA.
No, Continuus Pharmaceuticals, Inc. is not classified as H-1B dependent.
Continuus Pharmaceuticals, Inc. is listed in 13 LCA filings in FY2023 and 1 in FY2026. The average listed offered wage changed from $120,231 to $110,000. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 21 LCAs (Δ 0 heavier vs Continuus Pharmaceuticals, Inc.); CERT-LOCK · WAGE-ELITE vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 21 LCAs (Δ 0 heavier vs Continuus Pharmaceuticals, Inc.); CERT-LOCK · WAGE-PAR vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 21 LCAs (Δ 0 heavier vs Continuus Pharmaceuticals, Inc.); CERT-SOFT · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
ABS(total_petitions) peer at 21 LCAs (Δ 0 heavier vs Continuus Pharmaceuticals, Inc.); CERT-LOCK · WAGE-PAR vs this page's MICRO-BOOK · CERT-LOCK · WAGE-PREMIUM.
MA pole at 3,809 LCAs stamps HEAVY-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Continuus Pharmaceuticals, Inc.'s MICRO-BOOK.
Open the MA state board after the ABS peers. Continuus Pharmaceuticals, Inc. stamps MICRO-BOOK · CERT-LOCK inside that worksite mix.
Continuus Pharmaceuticals, Inc.'s WAGE-PREMIUM offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Continuus Pharmaceuticals, Inc. to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.